Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

1.4K
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.4K
Inhaled Medications01:23

Inhaled Medications

936
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
936
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Hyperpnea and Hyperventilation01:25

Hyperpnea and Hyperventilation

3.4K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
3.4K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

655
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
655

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transradial Renal Angioplasty and Stent Placement for Systemic Hypertension Caused by Severe Unilateral Renovascular Stenosis.

Cureus·2023
Same author

Revisiting the Historical Origins of Clinically Meaningful Coronary Artery Obstruction.

Mayo Clinic proceedings·2017
Same author

Electronic Stethoscope for Coronary Stenosis Detection.

The American journal of medicine·2017
Same author

The 50% coronary stenosis.

The American journal of cardiology·2015
Same author

High-intensity cardiac rehabilitation training of a firefighter after placement of an implantable cardioverter-defibrillator.

Proceedings (Baylor University. Medical Center)·2014
Same author

Abnormal origin of the left internal thoracic artery detected only by computed tomography.

Proceedings (Baylor University. Medical Center)·2013

Related Experiment Video

Updated: Mar 8, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.3K

Inhaler syncope.

Robert L Rosenthal1, Jay O Franklin1

  • 1Division of Cardiology, Baylor Heart and Vascular Hospital, Dallas, Texas.

Proceedings (Baylor University. Medical Center)
|January 28, 2017
PubMed
Summary
This summary is machine-generated.

Asthma inhaler use can trigger reflex bradycardia and asystole, leading to syncope in some individuals. This study identifies a new cause of fainting related to breathing and asthma medication.

More Related Videos

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.6K
A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

5.9K

Related Experiment Videos

Last Updated: Mar 8, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.3K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.6K
A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

5.9K

Area of Science:

  • Cardiology
  • Pulmonology
  • Pharmacology

Background:

  • Syncope, or fainting, is often triggered by physiological responses to activities like coughing or laughing.
  • Certain medical conditions and medications can also precipitate syncopal episodes.

Observation:

  • A novel cause of syncope was observed, linked to the use of asthma inhalers.
  • This syncope was characterized by reflex bradycardia (slow heart rate) and asystole (cessation of heartbeat).

Findings:

  • The use of asthma inhalers can induce a significant physiological response, causing reflex bradycardia and asystole.
  • This represents a previously undocumented trigger for syncope.

Implications:

  • Clinicians should consider asthma inhaler use as a potential cause of syncope in susceptible patients.
  • Further research into the mechanisms of breathing-related bradycardia is warranted.